Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Kapp

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Gynecologic Oncology|March 16, 2021
Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics studyMary Kathryn Abel, Cheng-I Liao, Chloe Chan, et al.
Cancer|February 3, 2011
Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canalJose G Bazan, Wendy Hara, Annie Hsu, et al.
Gynecologic Oncology|August 24, 2020
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefitMichael T Richardson, David P Mysona, David A Klein, et al.
Obstetrics and Gynecology|January 6, 2022
Symptoms of Women With High-Risk Early-Stage Ovarian CancerJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|December 5, 2017
Cumulative dose of radiation therapy of hepatocellular carcinoma patients and its deterministic relation to radiation-induced liver diseasePu Huang, Gang Yu, Daniel S Kapp, et al.
Gynecologic Oncology|June 24, 2019
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patientsKatherine C Fuh, James J Java, John K Chan, et al.
Gynecologic Oncology|October 16, 2022
The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Gynecologic Oncology|December 22, 2023
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Cancers|March 13, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United StatesCollin A Sitler, Chunqiao Tian, Chad A Hamilton, et al.
JAMA Network Open|May 15, 2025
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical HysterectomyChristopher M Tarney, Chunqiao Tian, Leslie M Randall, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|March 16, 2021
Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics studyMary Kathryn Abel, Cheng-I Liao, Chloe Chan, et al.
Cancer|February 3, 2011
Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canalJose G Bazan, Wendy Hara, Annie Hsu, et al.
Gynecologic Oncology|August 24, 2020
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefitMichael T Richardson, David P Mysona, David A Klein, et al.
Obstetrics and Gynecology|January 6, 2022
Symptoms of Women With High-Risk Early-Stage Ovarian CancerJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|December 5, 2017
Cumulative dose of radiation therapy of hepatocellular carcinoma patients and its deterministic relation to radiation-induced liver diseasePu Huang, Gang Yu, Daniel S Kapp, et al.
Gynecologic Oncology|June 24, 2019
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patientsKatherine C Fuh, James J Java, John K Chan, et al.
Gynecologic Oncology|October 16, 2022
The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Gynecologic Oncology|December 22, 2023
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Cancers|March 13, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United StatesCollin A Sitler, Chunqiao Tian, Chad A Hamilton, et al.
JAMA Network Open|May 15, 2025
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical HysterectomyChristopher M Tarney, Chunqiao Tian, Leslie M Randall, et al.
Pageof 15